ENDRA Life Sciences Inc.
Price Action
Technical Summary
WEAKENINGENDRA Life Sciences Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 46), showing significant lag compared to the market leaders. Earnings growth of 41% provides fundamental context to the price action. Investors should exercise caution due to high volatility (106% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.83 | +2.27% | ABOVE |
| 50 SMA | $5.02 | -1.68% | BELOW |
| 100 SMA | $4.59 | +7.56% | ABOVE |
| 150 SMA | $4.68 | +5.64% | ABOVE |
| 200 SMA | $4.93 | +0.19% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NDRA in an uptrend right now?
NDRA has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is NDRA overbought or oversold?
NDRA's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.
Is NDRA outperforming the market?
NDRA has a Relative Strength (RS) Rating of 46 out of 99. NDRA is currently lagging the broader market.
Where is NDRA in its 52-week range?
NDRA is trading at $4.94, which is 41% of its 52-week high ($11.96) and 22% above its 52-week low ($2.96).
How volatile is NDRA?
NDRA has a Beta of 1.38 and 52-week volatility of 106%. It's more volatile than the S&P 500 - expect bigger swings.